ES2063465T3 - Nuevos derivados n-sustituidos de alfa-mercapto-alquilaminas, su procedimiento de preparacion y los productos intermedios obtenidos, su aplicacion como medicamentos y composiciones que los contienen. - Google Patents

Nuevos derivados n-sustituidos de alfa-mercapto-alquilaminas, su procedimiento de preparacion y los productos intermedios obtenidos, su aplicacion como medicamentos y composiciones que los contienen.

Info

Publication number
ES2063465T3
ES2063465T3 ES91401858T ES91401858T ES2063465T3 ES 2063465 T3 ES2063465 T3 ES 2063465T3 ES 91401858 T ES91401858 T ES 91401858T ES 91401858 T ES91401858 T ES 91401858T ES 2063465 T3 ES2063465 T3 ES 2063465T3
Authority
ES
Spain
Prior art keywords
sub
eventually
medicines
application
alquilaminas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91401858T
Other languages
English (en)
Inventor
Francois Clemence
Martret Odile Le
Francis Petit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2063465T3 publication Critical patent/ES2063465T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA SOLICITUD SE REFIERE A LOS PRODUCTOS DE FORMULA (I SUB A): DONDE N REPRESENTA 0 A 4, R SUB 1 REPRESENTA HIDROGENO O R SUB 5 -CO-, REPRESENTANDO R SUB 5: INILO, EVENTUALMENTE SUSTITUIDO EVENTUALMENTE SUSTITUIDOS; R SUB 10 Y R SUB 11; O BIEN FORMAN CON EL ATOMO DE NITROGENO UN CICLO QUE CONTIENE EVENTUALMENTE UNO O VARIOS HETEROATOMOS EVENTUALMENTE SUSTITUIDO, O BIEN REPRESENTAN: EVENTUALMENTE SUSTITUIDOS. A REPRESENTA ALQUILENO, ALQUENILENO EVENTUALMENTE SUSTITUIDO POR OH O OAL SUB R DE ENLACE SENCILLO, R SUB 2 REPRESENTA OXIGENO O AZUFRE R SUB 3A Y R SUB 4A O BIEN FORMAN CON EL AZOTE UN CICLO QUE CONTIENE EVENTUALMENTE UNO O VARIOS MAS HETEROATOMOS, EVENTUALMENTE SUSTITUIDOS, O BIEN REPRESENTAN: BOXI; CIANO; ALQUILO, ALQUENILO O ALQUINILO; R SUB C O R SUB C -O-, R SUB C REPRESENTA UN CICLO ALIFATICO O ARILICO; BAJO TODAS LAS ISOMERAS, Y SUS SALES, SU PREPARACION, SU APLICACION COMO MEDICAMENTOS
ES91401858T 1990-07-05 1991-07-04 Nuevos derivados n-sustituidos de alfa-mercapto-alquilaminas, su procedimiento de preparacion y los productos intermedios obtenidos, su aplicacion como medicamentos y composiciones que los contienen. Expired - Lifetime ES2063465T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9008539A FR2664269B1 (fr) 1990-07-05 1990-07-05 Nouveaux derives n-substitues d'alpha-mercapto alkylamines, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.

Publications (1)

Publication Number Publication Date
ES2063465T3 true ES2063465T3 (es) 1995-01-01

Family

ID=9398389

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91401858T Expired - Lifetime ES2063465T3 (es) 1990-07-05 1991-07-04 Nuevos derivados n-sustituidos de alfa-mercapto-alquilaminas, su procedimiento de preparacion y los productos intermedios obtenidos, su aplicacion como medicamentos y composiciones que los contienen.

Country Status (9)

Country Link
US (2) US5190974A (es)
EP (1) EP0465369B1 (es)
JP (1) JPH04230358A (es)
AT (1) ATE104278T1 (es)
CA (1) CA2046264A1 (es)
DE (1) DE69101673T2 (es)
DK (1) DK0465369T3 (es)
ES (1) ES2063465T3 (es)
FR (1) FR2664269B1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
US5508272A (en) * 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
US5616775A (en) * 1994-05-05 1997-04-01 Bristol-Myers Squibb Co. Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
WO2000007985A1 (en) * 1998-08-05 2000-02-17 Santen Pharmaceutical Co., Ltd. Novel urea derivatives bearing nitrogenous aromatic heterocycles
CN1188394C (zh) * 1999-04-07 2005-02-09 参天制药株式会社 N－取代－n′－取代脲衍生物及含有它的药物组合物
AU3673300A (en) 1999-04-07 2000-11-14 Santen Pharmaceutical Co. Ltd. N-substituted-n'-substituted urea derivative and use thereof as tnf-alpha production inhibitor
ES2353020T3 (es) 2000-05-31 2011-02-24 Santen Pharmaceutical Co., Ltd. (piridinil)alquil-amidas o -ureas como inhibidores de la producción del tnf-alfa.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2835704A (en) * 1953-01-06 1958-05-20 Merck & Co Inc Pantetheine intermediates
DE2550964A1 (de) * 1975-11-13 1977-08-04 Basf Ag Hydantoinderivate
US4113715A (en) * 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
IL65567A (en) * 1981-05-20 1985-11-29 Robins Co Inc A H N-(arylthioalkyl)-n'-(aminoalkyl)ureas and pharmaceutical compositions containing them
US5041552A (en) * 1990-05-25 1991-08-20 Warner-Lambert Company Amino acid derivatives with angiotensin II antagonist properties

Also Published As

Publication number Publication date
US5674864A (en) 1997-10-07
ATE104278T1 (de) 1994-04-15
EP0465369B1 (fr) 1994-04-13
DE69101673T2 (de) 1994-08-11
JPH04230358A (ja) 1992-08-19
FR2664269B1 (fr) 1992-10-02
US5190974A (en) 1993-03-02
EP0465369A1 (fr) 1992-01-08
DE69101673D1 (de) 1994-05-19
DK0465369T3 (da) 1994-06-27
CA2046264A1 (fr) 1992-01-06
FR2664269A1 (fr) 1992-01-10

Similar Documents

Publication Publication Date Title
ES485274A1 (es) Un procedimiento para la preparacion de derivados de fenil- piperacina
ES472742A1 (es) Procedimiento para la obtencion de derivados de alqueno
ES2036551T3 (es) Compuestos heterociclicos.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2097847T3 (es) Inhibidores de encefalinasa y eca con un radical carboxialquilo.
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ECSP078064A (es) NUEVOS DERIVADOS de 2,4-DIANILINOPIRIMIDINAS, SU PREPARACIÓN, COMO MEDICAMENTOS, COMPOSICIONES FARMACÉUTICAS Y PRINCIPALMENTE COMO INHIBIDORES DE IKK
ES2083773T3 (es) Derivados de 1,3-dihidro-2h-imidazo(4,5-b)quinolin-2-ona como inhibidores de fosfodiesterasa.
ES8704926A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ES2181928T3 (es) Derivados de diester de acido fosfonico.
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
ES2059804T3 (es) Procedimiento de preparacion de eteres de oxima de propenona.
ES2069281T3 (es) Derivado de fenantreno.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES2001270A6 (es) Procedimidento para preparar derivados de azolil-ciclopropiletanol
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
AR240815A2 (es) Procedimiento para preparar derivados de los acidos benzofuran-5-il y benzotiofen-5-il acetico y propionico
ES463971A1 (es) Perfeccionamientos en o relacionados con compuestos organi- cos.
DK0452204T3 (da) Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
ES2038776T3 (es) Procedimiento de preparacion de derivados de la oxima del 1,2,5,6-tetrahidropiridin-3-carboxaldehido.
ES2157541T3 (es) Derivados de n-bencil-piperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES8306747A1 (es) Un procedimiento para la preparacion de derivados del tetrazol.
ES516158A0 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
ES460705A1 (es) Un procedimiento para la preparacion de nuevos derivados de acido pirrol-1-carboxilico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 465369

Country of ref document: ES